Earnings Call · Q4 FY2025·2026-02-26

Q4 25EPS -7.96%·Rev n/aQ3 25EPS +20.97%·Rev n/aQ2 25EPS +2.80%·Rev n/aQ1 25EPS +2.76%·Rev n/a⚠ consensus missing

COLLEGIUM PHARMACEUTICAL, INC COLL

Ian Karp — Investor Relations

Vikram Karnani — President and Chief Executive Officer

Scott Dreyer — Chief Commercial Officer

Colleen Tupper — Chief Financial Officer

−3.3%1d on move date−2.8% vs SPY3d−9.1%5d−13.4%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more COLL calls or request research access.

More COLL calls Browse calls Request research access